Operating Lease, Right-of-Use Asset in USD of Tvardi Therapeutics, Inc. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Tvardi Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2019 to Q3 2025.
  • Tvardi Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $163K.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Tvardi Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $163K 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $181K -$3.47M -95% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $0 -$3.83M -100% 31 Mar 2025 10-Q 13 May 2025
Q4 2024 $216K -$4.65M -95.6% 31 Dec 2024 10-Q 13 Nov 2025
Q2 2024 $3.65M +$2.85M +360% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $3.83M +$2.65M +226% 31 Mar 2024 10-Q 13 May 2024
Q4 2023 $4.86M +$3.31M +214% 31 Dec 2023 10-K 11 Mar 2025
Q3 2023 $7.11M +$5.19M +271% 30 Sep 2023 10-Q 13 Nov 2023
Q2 2023 $792K -$1.49M -65.2% 30 Jun 2023 10-Q 07 Aug 2023
Q1 2023 $1.18M -$1.45M -55.3% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $1.55M -$1.42M -47.8% 31 Dec 2022 10-K 06 Mar 2024
Q3 2022 $1.92M -$1.39M -42.1% 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 $2.28M -$1.36M -37.4% 30 Jun 2022 10-Q 08 Aug 2022
Q1 2022 $2.63M -$1.33M -33.7% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 $2.97M -$1.31M -30.5% 31 Dec 2021 10-K 06 Mar 2023
Q3 2021 $3.31M +$656K +24.7% 30 Sep 2021 10-Q 08 Nov 2021
Q2 2021 $3.64M +$816K +28.9% 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 $3.96M +$1.09M +37.8% 31 Mar 2021 10-Q 10 May 2021
Q4 2020 $4.28M +$1.24M +40.9% 31 Dec 2020 10-K 01 Mar 2022
Q3 2020 $2.65M -$538K -16.9% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $2.83M -$519K -15.5% 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 $2.88M -$616K -17.6% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 $3.04M 31 Dec 2019 10-K 25 Feb 2021
Q3 2019 $3.19M 30 Sep 2019 10-Q 05 Nov 2019
Q2 2019 $3.34M 30 Jun 2019 10-Q 07 Aug 2019
Q1 2019 $3.49M 31 Mar 2019 10-Q 07 May 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.